Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Patricia Bach"'
Publikováno v:
Polymers, Vol 12, Iss 4, p 787 (2020)
The incorporation of nanoparticles into soft matrices opens a broad spectrum of novel property combinations. However, one of the major challenges for these systems remains the compatibilization of particles with the surrounding matrix by proper surfa
Externí odkaz:
https://doaj.org/article/4d5e143add9143df8fa8ae2321c06ec9
Autor:
Christian J. Buchholz, Hanno Glimm, Michael D. Mühlebach, Christel Herold-Mende, Ulrich M. Lauer, Ian C.D. Johnston, Claudia R. Ball, Iris Voelker, Gundula Braun, Zoltan Gal, Christopher Hoffmann, Tobias Abel, Patricia Bach
Tumor-initiating cells (TIC) are critical yet evasive targets for the development of more effective antitumoral strategies. The cell surface marker CD133 is frequently used to identify TICs of various tumor entities, including hepatocellular cancer a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c32bb3485e8b4d1afd23235687383c8
https://doi.org/10.1158/0008-5472.c.6505040.v1
https://doi.org/10.1158/0008-5472.c.6505040.v1
Publikováno v:
Polymers
Volume 12
Issue 4
Polymers, Vol 12, Iss 787, p 787 (2020)
Volume 12
Issue 4
Polymers, Vol 12, Iss 787, p 787 (2020)
The incorporation of nanoparticles into soft matrices opens a broad spectrum of novel property combinations. However, one of the major challenges for these systems remains the compatibilization of particles with the surrounding matrix by proper surfa
Autor:
Janna Seifried, Cheick Coulibaly, Iris Völker, Roland Plesker, Patricia Bach, Christian J. Buchholz, Michael D. Mühlebach, Ulrich M. Lauer, Sabine Heidmeier, Tobias Abel
Publikováno v:
Human Gene Therapy Clinical Development. 24:11-22
Oncolytic viruses such as measles virus (MV) represent a new class of therapeutic agents that might help to overcome current limitations in cancer therapy. Although MV-based virotherapeutics already have entered clinical testing for various tumor ent
Autor:
Ulrich M. Lauer, Gundula Braun, Hanno Glimm, Iris Voelker, Claudia R. Ball, Christel Herold-Mende, Christopher M. Hoffmann, Patricia Bach, Zoltan Gal, Ian C.D. Johnston, Tobias Abel, Michael D. Mühlebach, Christian J. Buchholz
Publikováno v:
Cancer Research. 73:865-874
Tumor-initiating cells (TIC) are critical yet evasive targets for the development of more effective antitumoral strategies. The cell surface marker CD133 is frequently used to identify TICs of various tumor entities, including hepatocellular cancer a
Autor:
Karl-Heinz Wiederhold, Matthias Staufenbiel, Thomas Deller, Christian J. Buchholz, Patricia Bach, Gundula Braun, Ulrich Kalinke, Jakob-A. Tschäpe, Janina K. Baade, Ferdinand Kopietz, Marco Prinz, Ulrike Müller
Publikováno v:
The Journal of Immunology. 182:7613-7624
In transgenic animal models, humoral immunity directed against the β-amyloid peptide (Aβ), which is deposited in the brains of AD patients, can reduce Aβ plaques and restore memory. However, initial clinical trials using active immunization with A
Autor:
Gerd Sutter, Ulrich Kalinke, Bernhard Odermatt, Christian J. Buchholz, Patricia Bach, Elisabeth Kamphuis
Publikováno v:
The Journal of Immunology. 178:5839-5847
Vesicular stomatitis virus (VSV) infection rapidly induces IFN-αβ that confers initial survival, whereas long-term protection is mediated by neutralizing IgG responses. Because coadministration of IFN-αβ can enhance Ab responses against soluble A
Autor:
Patricia Bach
Publikováno v:
PsycCRITIQUES. 60
Autor:
Patricia Bach
Publikováno v:
Incorporating Acceptance and Mindfulness into the Treatment of Psychosis: Current Trends and Future Directions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b98fbd9a78ded591b5930c0695839097
https://doi.org/10.1093/med:psych/9780199997213.003.0004
https://doi.org/10.1093/med:psych/9780199997213.003.0004
Publikováno v:
Expert Opinion on Biological Therapy. 6:293-300
Prion diseases, also called transmissible spongiform encephalopathies, are a group of fatal neurodegenerative conditions that affect humans and a wide variety of animals. There is no therapeutic or prophylactic approach against prion diseases availab